Over longer horizons, Revenue CAGR averages -2.21% over 3 years and 0.29% over 5 years; the trailing 12 months came in at +1.37%.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how the company's top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
BIO Revenue CAGR Chart
Bio-Rad Laboratories, Inc. (BIO)
tgmcharts.com
BIO Quarterly Revenue Growth (YoY)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
tgmcharts.com
Revenue
BIO Quarterly Revenue
$651.00M
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $651.00M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
tgmcharts.com
Q4 FY2024
2024-12-31
$667.48M
+2.7%
-2.0%
Q3 FY2024
2024-09-30
$649.73M
+1.8%
+2.8%
Q2 FY2024
2024-06-30
$638.48M
+4.5%
-6.3%
Q1 FY2024
2024-03-31
$610.82M
-10.3%
-9.8%
Q4 FY2023
2023-12-31
$681.18M
+7.8%
-6.7%
Q3 FY2023
2023-09-30
$632.12M
-7.2%
-7.1%
Q2 FY2023
2023-06-30
$681.11M
+0.6%
-1.4%
Q1 FY2023
2023-03-31
$676.84M
-7.3%
-3.3%
Q4 FY2022
2022-12-31
$730.29M
+7.3%
-0.3%
Q3 FY2022
2022-09-30
$680.80M
-1.5%
-8.9%
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.